{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:11:14Z","timestamp":1791612674157,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T00:00:00Z","timestamp":1485388800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00277-017-2924-y","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T20:06:15Z","timestamp":1485374775000},"page":"589-596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7530-8892","authenticated-orcid":false,"given":"Ferras","family":"Alashkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Vance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f6rte","family":"Herich-Terh\u00fcrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Preising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"D\u00fchrsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"R\u00f6th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,26]]},"reference":[{"issue":"6","key":"2924_CR1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/ejh.12520","volume":"94","author":"J Schubert","year":"2015","unstructured":"Schubert J, R\u00f6th A (2015) Update on paroxysmal nocturnal haemoglobinuria: on the long way to understand the principles of the disease. Eur J Haematol 94(6):464\u2013473","journal-title":"Eur J Haematol"},{"key":"2924_CR2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1600-0609.2011.01701.x","volume":"87","author":"A R\u00f6th","year":"2011","unstructured":"R\u00f6th A, D\u00fchrsen U (2011) Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab. Eur J Haematol 87:473\u2013479","journal-title":"Eur J Haematol"},{"issue":"12","key":"2924_CR3","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen P, Young NS, Schubert J, Brodsky RA, Soci\u00e9 G, Muus P et al (2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355(12):1233\u20131243","journal-title":"N Engl J Med"},{"issue":"1","key":"2924_CR4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/bjh.12347","volume":"162","author":"P Hillmen","year":"2013","unstructured":"Hillmen P, Muus P, R\u00f6th A, Elebute MO, Risitano AM, Schrezenmeier H et al (2013) Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 162(1):62\u201373","journal-title":"Br J Haematol"},{"issue":"25","key":"2924_CR5","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","volume":"117","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M et al (2011) Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood [Internet] 117(25):6786\u20136792","journal-title":"Blood [Internet]"},{"issue":"9","key":"2924_CR6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1634\/theoncologist.2008-0086","volume":"13","author":"A Dmytrijuk","year":"2008","unstructured":"Dmytrijuk A, Robie-Suh K, Cohen MH, Rieves D, Weiss K, Pazdur R (2008) FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Oncologist 13(9):993\u20131000","journal-title":"Oncologist"},{"key":"2924_CR7","unstructured":"Control EC for DP and 2012 Annual epidemiological report\u2014reporting on 2010 surveillance data and 2011 epidemic intelligence data"},{"issue":"4","key":"2924_CR8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CMR.00048-09","volume":"23","author":"S Ram","year":"2010","unstructured":"Ram S, Lewis LA, Rice PA (2010) Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev 23(4):740\u2013780","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"2924_CR9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","volume":"4","author":"JE Figueroa","year":"1991","unstructured":"Figueroa JE, Densen P (1991) Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4(3):359\u2013395","journal-title":"Clin Microbiol Rev"},{"issue":"19","key":"2924_CR10","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","volume":"280","author":"NE MacDonald","year":"1998","unstructured":"MacDonald NE, Halperin SA, Law BJ, Forrest B, Danzig LE, Granoff DM (1998) Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. JAMA 280(19):1685\u20131689","journal-title":"JAMA"},{"issue":"3","key":"2924_CR11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/515346","volume":"178","author":"DM Granoff","year":"1998","unstructured":"Granoff DM, Gupta RK, Belshe RB, Anderson EL (1998) Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. The Journal of infectious diseases 178(3):870\u2013874","journal-title":"The Journal of infectious diseases"},{"issue":"50","key":"2924_CR12","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1016\/j.vaccine.2009.09.082","volume":"27","author":"RM Voer de","year":"2009","unstructured":"de Voer RM, van der Klis FRM, Engels CWAM, Schepp RM, van de Kassteele J, Sanders EAM et al (2009) Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults. Vaccine 27(50):6974\u20136982","journal-title":"Vaccine"},{"issue":"17\u201318","key":"2924_CR13","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","volume":"23","author":"R Borrow","year":"2005","unstructured":"Borrow R, Balmer P, Miller E (2005) Meningococcal surrogates of protection\u2014serum bactericidal antibody activity. Vaccine 23(17\u201318):2222\u20132227","journal-title":"Vaccine"},{"issue":"5","key":"2924_CR14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1515\/JLM.2009.050","volume":"33","author":"U Vogel","year":"2009","unstructured":"Vogel U, Elias J, Claus H, Frosch M (2009) Labordiagnostik von Neisseria meningitidis aus der Sicht des Nationalen Referenzzentrums f\u00fcr Meningokokken\/laboratory diagnosis of Neisseria meningitidis from the viewpoint of the German Reference Laboratory. LaboratoriumsMedizin 33(5):245\u2013253","journal-title":"LaboratoriumsMedizin"},{"key":"2924_CR15","first-page":"1","volume":"2007","author":"Agency EM","year":"2007","unstructured":"Agency EM (2007) EMEA fact sheet. Eculizumab 2007:1\u201341","journal-title":"Eculizumab"},{"issue":"12","key":"2924_CR16","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00207-09","volume":"16","author":"KS Reisinger","year":"2009","unstructured":"Reisinger KS, Baxter R, Block SL, Shah J, Bedell L, Dull PM (2009) Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra. Clinical and vaccine immunology\u00a0: CVI 16(12):1810\u20131815","journal-title":"Clinical and vaccine immunology\u00a0: CVI"},{"issue":"2","key":"2924_CR17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/315284","volume":"181","author":"P Richmond","year":"2000","unstructured":"Richmond P, Kaczmarski E, Borrow R, Findlow J, Clark S, McCann R et al (2000) Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. The Journal of infectious diseases. 181(2):761\u2013764","journal-title":"The Journal of infectious diseases."},{"key":"2924_CR18","first-page":"105","volume":"34","author":"H Neuhauser","year":"2015","unstructured":"Neuhauser H (2015) Empfehlungen der St\u00e4ndischen Impfkommission (STIKO) am RKI-Stand: August 2015. Epidemiologisches Bulletin 34:105\u2013114","journal-title":"Epidemiologisches Bulletin"},{"issue":"6","key":"2924_CR19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00005792-199311000-00002","volume":"72","author":"AE Platonov","year":"1993","unstructured":"Platonov AE, Beloborodov VB, Vershinina IV (1993) Meningococcal disease in patients with late complement component deficiency: studies in the U.S.S.R. Medicine 72(6):374\u2013392","journal-title":"Medicine"},{"issue":"1","key":"2924_CR20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/viru.26515","volume":"5","author":"LA Lewis","year":"2014","unstructured":"Lewis LA, Ram S (2014) Meningococcal disease and the complement system. Virulence 5(1):98\u2013126","journal-title":"Virulence"},{"issue":"3","key":"2924_CR21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02918259","volume":"12","author":"J Figueroa","year":"1993","unstructured":"Figueroa J, Andreoni J, Densen P (1993) Complement deficiency states and meningococcal disease. Immunol Res 12(3):295\u2013311","journal-title":"Immunol Res"},{"issue":"27\u201330","key":"2924_CR22","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/S0264-410X(03)00440-7","volume":"21","author":"AE Platonov","year":"2003","unstructured":"Platonov AE, Vershinina IV, Kuijper EJ, Borrow R, K\u00e4yhty H (2003) Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine. Vaccine 21(27\u201330):4437\u20134447","journal-title":"Vaccine"},{"issue":"2","key":"2924_CR23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1128\/IAI.01044-09","volume":"78","author":"BC Hellerud","year":"2010","unstructured":"Hellerud BC, Aase A, Herstad TK, Naess LM, Kristiansen LH, Tr\u00f8seid A-MS et al (2010) Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies. Infect Immun 78(2):802\u2013809","journal-title":"Infect Immun"},{"issue":"3","key":"2924_CR24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40259-013-0029-2","volume":"27","author":"NJ Carter","year":"2013","unstructured":"Carter NJ (2013) Multicomponent meningococcal serogroup B vaccine (4CMenB; Bexsero\u00ae): a review of its use in primary and booster vaccination. BioDrugs\u00a0: clinical immunotherapeutics, biopharmaceuticals and gene therapy 27(3):263\u2013274","journal-title":"BioDrugs\u00a0: clinical immunotherapeutics, biopharmaceuticals and gene therapy"},{"key":"2924_CR25","doi-asserted-by":"crossref","unstructured":"Vesikari T, \u00d8stergaard L, Diez-Domingo J, Wysocki J, Flodmark C-E, Beeslaar J, et al. 2015 Meningococcal serogroup B bivalent rLP2086 vaccine elicits broad and robust serum bactericidal responses in healthy adolescents. J Pediatric Infect Dis Soc","DOI":"10.1093\/jpids\/piv039"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-2924-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-2924-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-2924-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T20:19:47Z","timestamp":1568751587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-2924-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["2924"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-2924-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,26]]}}}